Eur Rev Med Pharmacol Sci 2019; 23 (1): 1-2
DOI: 10.26355/eurrev_201901_16739

Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis

G. Franci, C. Dell’Aversana, D. Stelitano, M. Rinaldi, L. Altucci

Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy. gianluigi.franci@unicampania.it

Free PDF Download

To cite this article

G. Franci, C. Dell’Aversana, D. Stelitano, M. Rinaldi, L. Altucci
Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 1
Pages: 1-2
DOI: 10.26355/eurrev_201901_16739

Publication History

Published online: 14 Jan 2019

Keywords Related articles:

  1. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis
  2. Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma
  3. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway
  4. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma
  5. Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients